FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a Supplemental Application for Bromocriptine Mesylate by ANI Pharmaceuticals, Inc. The provided excerpt does not specify a new disease indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Hyperprolactinemia
• Parkinson Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bromocriptine mesylate (bromocriptine mesylate)

Snippet

SUPPL AP for BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)